Research finds no correlation between regulatory T cells and survival in glioblastoma

April 16, 2015

Using a novel methodology of epigenetic quantitative analysis, Dartmouth-Hitchcock's Norris Cotton Cancer Center's interdisciplinary team of investigators led by Camilo Fadul, MD, found no correlation between regulatory T cells (Tregs) and survival in the tumor microenvironment or blood, even when adjusting for well-known prognostic factors. Titled, "Regulatory T Cells Are Not a Strong Predictor of Survival for Patients with Glioblastoma," the findings were published in Neuro-Oncology.

"The traditional methods to quantify Tregs may be subjective and result in variability that may explain, in part, the controversial results found in the past," said Fadul. "We used epigenetic , a novel methodology that more accurately measures lymphocyte populations including Tregs in tumor tissue and peripheral blood."

Patients with glioblastoma, the most frequent and malignant type of brain cancer, exhibit tumor induced . Regulatory T are one of the types of cells in charge of controlling the immune system in the healthy recognition of self (tolerance) and non-self (foreign) antigens. Patients with glioblastoma have a higher proportion of Tregs than healthy controls, but how important the Tregs are in suppressing the immune system, and if that correlates with prognosis, has been controversial.

Fadul's team studied the correlation with survival, of the Tregs in the as well as in peripheral blood of 25 patients with newly diagnosed glioblastoma. They examined tumor-infiltrating Tregs and CD3+ T cells using quantitative DNA demethylation analysis (epigenetic qPCR) and by immunohistochemistry, and peripheral blood Treg proportions measured by flow cytometry. Further analysis used data from The Cancer Genome Atlas to correlate expression of Treg markers with patient survival and glioblastoma subtypes.

"Our finding of no correlation between Tregs and survival in glioblastoma has implications for the design of future immune therapy clinical trials," said Fadul.

The Dartmouth investigators hypothesize that an immune "net score," which takes into account the proportion of regulatory and effector immune cells as well as the expression of co-stimulatory and inhibitory receptors by both cancer and immune cells, will be a useful indicator of the patient's immune status with prognostic and therapeutic implications.

Looking forward, Fadul is analyzing 100 glioblastoma samples from another medical center and using the same novel methodology to determine a model that may allow neuro-oncologists to prognosticate and personalize the therapy approach.

Explore further: Team discovers mechanism responsible for tumor invasion in brain cancer

More information: Neuro Oncol (2015). DOI: 10.1093/neuonc/nou363

Related Stories

Team discovers mechanism responsible for tumor invasion in brain cancer

April 9, 2015
A neuro-oncology research team at Dartmouth's Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of ...

T cell receptor ensures Treg functionality

January 8, 2015
Misdirected immune responses that target the body's own tissue can result in diseases. regulatory T cells combat this effect by suppressing excessive immune responses and responses against our own bodies. Until now, scientists ...

Itch maintains regulatory T cell stability

October 26, 2013
Regulatory T cells (Tregs) function to suppress immune responses of other cells, and their dysfunction has been associated with development of immune disorders. Recent studies suggest that Tregs maintain plasticity even after ...

Researchers find importance of regulatory T-cells generated early in life

March 31, 2015
(MedicalXpress)—Originating in the thymus, the autoimmune regulator (Aire) protein controls a key mechanism that prevents the immune system from attacking the body itself. Individual T cells attack different substances; ...

Balancing T cell populations

November 25, 2013
Depending on the signals received, naïve T cells are able to differentiate into mature T cell populations, which play different roles in the immune system. For example, regulatory T cells (Tregs) are important for tamping ...

Recommended for you

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

A metabolic treatment for pancreatic cancer?

August 15, 2017
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.